← Insider buys
PVLA

Palvella Therapeutics, Inc. · Healthcare

Director George M Jenkins sold $3.6M of Palvella Therapeutics, Inc.

Sold$3,579,476
$130.16Price
27,500Shares
−17%Stake

What PVLA did after the filing

Filed Oct 14Copier in Oct 15
The stock from Thu, Oct 15 open, $123.58
+1.2%
S&P 500, same days
−0.8%

6 of 30 trading days so far, to the Oct 23 close.

Traded Mon, Oct 12. Filed Wed, Oct 14, 7:14 PM ET, after the close. Returns use the Oct 15 open and the Oct 23 close. Not investment advice.